Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>FL *** > Treatment > Co: USA. S. IbritumoMAb Tiuxetan>

---

Co: USA. S. IbritumoMAb Tiuxetan>'s subsections
(*) EU Approval Date: ?
(*) USA Approval Date: ?
>Has 3 Parts>
Company
Patent>Assignee; Claims; No.; Etc.
RadioImmunoTherapy
TradeMark
TradeMark Web-Site (USA)

Co: USA. S. IbritumoMAb Tiuxetan>'s products
This section has no products